Figure 2.

Desirability of outcome ranking distribution by treatment groups for ZEPHyR and VITAL. The events include absence of clinical response, infectious complications, serious adverse events, and death (definitions included in Figure 1). Abbreviations: LZD, linezolid; TZD, tedizolid; VAN, vancomycin.